BIO

Aleksandra Filipovic MD PhD, is the Head of Oncology at PureTech Health, a clinical stage biopharma dedicated to developing novel therapies for challenging indications in oncology and other disease areas. She is a medical oncologist practicing at Imperial College London where she also holds an honorary lecturer position.

She acquired her PhD and completed post-doctoral studies at Imperial College, in the area of cancer cell biology and from there worked at and with Brystol Myers Squibb and consulted for AstraZeneca, before joining PureTech.

In addition to her clinical and scientific/drug development roles, Aleksandra is a Scientific and Clinical Advisor to Sharing Progress in Cancer Care (SPCC), a global platform that reached the whole of the oncology community, where she designs educational content. She is on the editorial Board of Holistic Integrated Oncology Journal and a member of ASCO, SITC, AACR, ESMO, ESO, SIO, BSIO.

Aleksandra is an accredited holistic clinician, and works as the Chief Purpose Officer and practitioner of the clinic she establishes in 2022, The H.E.A.L. Clinic. She integrates a whole patient centered approach into all areas of her practice.